__timestamp | BeiGene, Ltd. | Johnson & Johnson |
---|---|---|
Wednesday, January 1, 2014 | 13035000 | 74331000000 |
Thursday, January 1, 2015 | 8816000 | 70074000000 |
Friday, January 1, 2016 | 1070000 | 71890000000 |
Sunday, January 1, 2017 | 238387000 | 76450000000 |
Monday, January 1, 2018 | 198220000 | 81581000000 |
Tuesday, January 1, 2019 | 428212000 | 82059000000 |
Wednesday, January 1, 2020 | 308874000 | 82584000000 |
Friday, January 1, 2021 | 1176283000 | 78740000000 |
Saturday, January 1, 2022 | 1415921000 | 79990000000 |
Sunday, January 1, 2023 | 2458779000 | 85159000000 |
Monday, January 1, 2024 | 61350000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical industry, Johnson & Johnson and BeiGene, Ltd. stand as two contrasting titans. Over the past decade, Johnson & Johnson has consistently demonstrated its dominance, with revenues peaking at approximately $85 billion in 2023, marking a steady growth of around 15% since 2014. In contrast, BeiGene, Ltd., a rising star in the biotech sector, has shown an impressive revenue surge, skyrocketing from a modest $13 million in 2014 to nearly $2.5 billion in 2023, reflecting a staggering growth rate of over 18,000%.
This analysis highlights the dynamic nature of the pharmaceutical market, where established giants and innovative newcomers coexist. As BeiGene continues to expand its footprint, the competition intensifies, promising exciting developments in the years to come.
Comparing Revenue Performance: Novo Nordisk A/S or Johnson & Johnson?
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Johnson & Johnson vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Cytokinetics, Incorporated?
Johnson & Johnson or Perrigo Company plc: Who Leads in Yearly Revenue?
Revenue Insights: Johnson & Johnson and Veracyte, Inc. Performance Compared
Johnson & Johnson and Mesoblast Limited: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Johnson & Johnson or Travere Therapeutics, Inc.?
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs BeiGene, Ltd.
Revenue Insights: BeiGene, Ltd. and Catalent, Inc. Performance Compared
Breaking Down Revenue Trends: BeiGene, Ltd. vs Jazz Pharmaceuticals plc
Comparing Revenue Performance: BeiGene, Ltd. or Arrowhead Pharmaceuticals, Inc.?